MODL-15. High-throughput combination drug screening identifies synergism between retinoic acid treatment and BCL-XL-inhibition in MYC(N)-driven medulloblastoma and neuroblastoma models
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.